Loading data
XAIRNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 7.68 m USD | 3.71 m USD | 1.16 m USD | — | — |
| Cost of revenue | 7.43 m USD | 5.37 m USD | 2.47 m USD | 555 k USD | — |
| Gross profit | 252 k USD | -1.66 m USD | -1.31 m USD | -555 k USD | — |
| Research and development expense | 10.24 m USD | 16.86 m USD | 24.36 m USD | 16.81 m USD | 11.8 m USD |
| Selling, general and administrative expense | 19.06 m USD | 26.02 m USD | 37.34 m USD | — | — |
| Operating profit | -29.04 m USD | -44.54 m USD | -63.01 m USD | -52.06 m USD | -40.71 m USD |
| Interest expense | — | — | 2.91 m USD | 30 k USD | 775 k USD |
| Profit before tax | -34.33 m USD | -48.48 m USD | -64.3 m USD | -59.4 m USD | -44.06 m USD |
| Net income (reported basis) | -34.33 m USD | -48.48 m USD | -64.3 m USD | -59.4 m USD | -43.18 m USD |
| Basic earnings per share | -4.01 USD/share | -13.77 USD/share | -1.82 USD/share | -1.86 USD/share | -1.68 USD/share |
| Diluted earnings per share | -4.01 USD/share | -13.77 USD/share | -1.82 USD/share | -1.86 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.